Journal of Surgical Research
Volume 155, Issue 2 , Pages 237-243 , August 2009

A Pilot Study of Proteomic Profiles of Human Hepatocellular Carcinoma in the United States

  • Jesus M. Matos, M.D.

      Affiliations

    • Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana
    • ,
  • Frank A. Witzmann, Ph.D.

      Affiliations

    • Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana
    • ,
  • O. William Cummings, M.D.

      Affiliations

    • Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana
    • ,
  • C. Max Schmidt

      Affiliations

    • Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana
    • Walther Oncology Center, Indianapolis, Indiana
    • Indiana University Cancer Center, Indianapolis, Indiana
    • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana
    • Richard L. Roudebush VA Medical Center, Indianapolis, Indiana
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Departments of Surgery and Biochem/Molecular Biology, Cancer Research Institute, 980 W Walnut Street C522, Indianapolis, IN 46202

Received 9 January 2008

References 

  1. Bosch FX, Ribes J, Cléries R, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191
  2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557
  3. El-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology. 2004;127(5 Suppl 1):S27
  4. Marrero JA. Hepatocellular carcinoma. Curr Opin Gastroenterol. 2005;21:308
  5. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10
  6. Olthoff KM. Surgical options for hepatocellular carcinoma: Resection and transplantation. Liver Transpl Surg. 1998;4(5 Suppl 1):S98
  7. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005;40:225
  8. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005;19:3
  9. Tanaka Y, Hanada K, Mizokami M, et al. Inaugural article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA. 2002;99:15584
  10. Srivatanakul P, Sriplung H, Deerasamee S. Epidemiology of liver cancer: An overview. Asian Pac J Cancer Prev. 2004;5:118
  11. Di Bisceglie AMO, Klein SE, Waggoner JL, et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol. 1991;86:335
  12. Aebersold R, Leavitt J. Sequence analysis of proteins separated by polyacrylamide gel electrophoresis: Towards an integrated protein database. Electrophoresis. 1990;11:517
  13. Steiner S, Witzmann FA. Proteomics: Applications and opportunities in preclinical drug development. Electrophoresis. 2000;21:2099
  14. Lahm HW, Langen H. Mass spectrometry: A tool for the identification of proteins separated by gels. Electrophoresis. 2000;21:2105
  15. Petricoin EF, Zoon KC, Kohn EC, et al. Clinical proteomics: Translating benchside promise into bedside reality. Nat Rev Drug Discov. 2002;1:683
  16. Kaplan RS, Pedersen PL. Determination of microgram quantities of protein in the presence of milligram levels of lipid with amido black 10B. Anal Biochem. 1985;150:97
  17. Candiano G, Bruschi M, Musante L, et al. Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis. 2004;25:1327
  18. Sun S, Lee NPY, Poon RTP, et al. Oncoproteomics of hepatocellular carcinoma: From cancer markers' discovery to functional pathways. Liver Intl. 2007;8:1021
  19. Lee IN, Chen CH, Sheu JC, et al. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. J Proteome Res. 2005;4:2062
  20. Li C, Tan YX, Zhou H, et al. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. Proteomics. 2005;5:1125
  21. Liang CR, Leow CK, Neo JC, et al. Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics. 2005;5:2258
  22. Blanc JF, Lalanne C, Plomion C, et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics. 2005;5:3778
  23. Luk JM, Lam CT, Siu AF, et al. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heatshock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics. 2006;6:1049
  24. Cheng CC, Liu YH, Ho CC, et al. The influence of plectin deficiency on stability of cytokeratin 18 in hepatocellular carcinoma. J Mol Histol. 2008;39:209
  25. Martin-Orozco N, Dong C. Inhibitory costimulation and anti-tumor immunity. Semin Cancer Biol. 2007;17:288
  26. Taylor MR, Peterson JA, Ceriani RL, et al. Cloning and sequence analysis of human butyrophilin reveals a potential receptor function. Biochim Biophys Acta. 1996;1306:1
  27. Scarpino S, Di Napoli A, Stoppacciaro A, et al. Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas. Clin Exp Immunol. 2007;149:504
  28. Shin GJ, Wilson NH. Overexpression of repulsive guidance molecule (RGM) a induces cell death through Neogenin in early vertebrate development. J Mol Histol. 2008;39:105
  29. Nieto-Miguel T, Fonteriz RI, Vay L, et al. Endoplasmic reticulum stress in the proapoptotic action of edelfosine in solid tumor cells. Cancer Res. 2007;67:10368
  30. Gu X, Shin BH, Akbarali Y, et al. Tel-2 is a novel transcriptional. J Biol Chem. 2001;276:9421
  31. Maeda T, Yagasaki F, Ishikawa M, et al. Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML. Blood. 2005;105:2115
  32. Nishida N, Nagasaka T, Nishimura T, et al. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology. 2008;47:908

PII: S0022-4804(08)00402-2

doi: 10.1016/j.jss.2008.06.008

Journal of Surgical Research
Volume 155, Issue 2 , Pages 237-243 , August 2009

Article Tools

* Image Usage & Resolution